Accelmed Partners — 2021 Investments

2 investments dated 2021 · listed companies and verified rows first · show all

Click Therapeuticsclicktherapeutics.com in 𝕏Oct 2021

Click Therapeutics develops, validates, and commercializes software-based prescription medical treatments, including software-enhanced drug products that combine digital therapeutics with pharmacotherapy.

BiotechDigital HealthHealthtechMedical DevicesNew York, US

David B. Klein(Founder and CEO)inRandall Stanicky(Executive Officer)inAnthony Costello(Director)Bruce Robertson(Director)Douglas Langa(Director)

BoardAlex Zisson(Director)

Board seatUri Geiger· per SEC Form D

Co-investorsH.I.G. Capital H.I.G. HealthBridge Partners Health Catalyst Capital Hikma Ventures Revelation Partners Sanofi Ventures +5 more

Corvia Medicalcorviamedical.com in 𝕏Jan 2021

Developer of a transcatheter InterAtrial Shunt Device to treat congestive heart failure.

BiotechTewksbury, US

George J. Fazio(Executive Officer, Director)inDan B. Curtis(Executive Officer)

BoardPaul LaViolette(Director)inKevin Gillis(Director)inGerald Brunk(Director)inIrit Yaniv(Director)in

Board seatUri Geiger· per SEC Form D

Co-investorsLumira Ventures General Catalyst SV Health Investors Third Rock Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.